Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy. [electronic resource]
Producer: 20200522Description: 431-439 p. digitalISSN:- 1365-2141
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow -- metabolism
- Bone Neoplasms -- diagnostic imaging
- Disease-Free Survival
- Female
- Fluorodeoxyglucose F18 -- pharmacokinetics
- Hodgkin Disease -- diagnostic imaging
- Humans
- Male
- Middle Aged
- Positron Emission Tomography Computed Tomography -- methods
- Radiopharmaceuticals -- pharmacokinetics
- Retrospective Studies
- Sweden -- epidemiology
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.